Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Small Cell Lung Carcinoma 30Lung Neoplasms 11Burkitt Lymphoma 11Lymphoma, Large B-Cell, Diffuse 10Recurrence 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 7Carcinoma, Non-Small-Cell Lung 7Hodgkin Disease 6Lymphoma, Non-Hodgkin 5Neuroblastoma 4Lymphoma, B-Cell 4Wilms Tumor 3Sarcoma, Ewing 3Neoplasms, Germ Cell and Embryonal 3Neoplasms 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Ganglioneuroblastoma 3Teratoma 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Plasmablastic Lymphoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroendocrine Tumors 2Multiple Myeloma 2

Interventions

Dexamethasone 120Lenalidomide 72daratumumab 69Bortezomib 56pomalidomide 45carfilzomib 42Cyclophosphamide 39Calcium Dobesilate 33Specimen Handling 31Biopsy 29Magnetic Resonance Spectroscopy 26belantamab mafodotin 21fludarabine 20talquetamab 19isatuximab 17iberdomide 17dexamethasone acetate 14dexamethasone 21-phosphate 14auricularum 14Melphalan 14fludarabine phosphate 12elotuzumab 12tocilizumab 9selinexor 8X-Rays 8Nivolumab 8trametinib 7Whole-Body Irradiation 6Sirolimus 6Crizotinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × Etoposide × 90 days × Clear all
NCT00734877 2026-05-22

TT4B

University of Arkansas

Phase 3 Active not recruiting
382 enrolled
Plasma cell

Multiple Myeloma

NCT00869232 2026-05-22

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

University of Arkansas

Phase 2 Active not recruiting
90 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡